RealClearHealth October 10, 2016 Archives

RealClearHealth AM Update

Trump and Clinton Spar Over Obamacare During Debate

Akin Oyedele Business Ins.

Mylan to Pay $465 Million EpiPen Settlement

Carolyn Y. Johnson Wonkblog

California Proves Obamacare Is Not a Disaster

Noam N. Levey Los Angeles Times

Chemical Weapon for Sale: China's Unregulated Narcotic

Kinetz & Butler AP

Anthem Refuses to Cover Pioneering Duchenne Drug

Sy Mukherjee Fortune

Mixed Results for Medicare Experiment

Guy Boulton USA Today

What Happens if Congress Doesn't Change Obamacare?

Caitlin Owens Morn. Consult

How Many Military Personnel, Vets Will Have PTSD in 2025?

M. S. Jalali The Conv.

This Drug Discount Program Is Increasing Cancer Care Costs

Debra Patt Stat

Insulin Prices Soar While Drugmakers’ Share Stays Flat

Roland & Loftus WSJ

Breast Cancer Awareness: A Chance For a New Conversation

Tricia Laursen The Hill

Got Zika? Lab Constraints Mean It's Often Hard to Know

Shefali Luthra KHN

Does Birth Control Raise Depression Risk? That's Complicated

Tara Haelle NPR

Drug-Addiction Epidemic Creates Crisis in Foster Care

Teresa Wiltz Stateline

Volunteers Canvass Medical Offices to Curb Opioid Misuse

Elana Gordon NW

RealClearHealth PM Update

No, Trump, Canadians Do Not Flee En Masse for US Healthcare

Julia Belluz Vox

Do Health Insurers Even Want to Sell Across State Lines?

Sarah Kliff WaPo

Medicare Signups: How to Prepare for 2017 Changes and Avoid Scams

Buck SB

Soda Giants Are Likened to Big Tobacco in Report on Lobbying

Kaplan Bloomberg